HECTOR COLON-RIVERA: Open Payments
NPI 1508132119 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,114 in 52 payments from 7 companies in 2025. Trend: 2023 $651 · 2024 $773 · 2025 $20,114
Speaker / faculty: $19,250Food & beverage: $752Travel & lodging: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $19,700 |
| Janssen Pharmaceuticals, Inc | 3 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $110 |
| Alkermes, Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Almatica Pharma LLC | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: VRAYLAR, INVEGA SUSTENNA, CAPLYTA, REXULTI, LOREEV XR, LYBALVI, ARISTADA, COBENFY.
Industry payments across PA — which companies pay providers there.
